Literature DB >> 28509301

AP-VAS 2012 case report: anti-glomerular basement membrane disease with high titer of myeloperoxidase anti-neutrophil cytoplasmic antibody-an autopsy case report.

Miho Otani1, Hiroki Shoji2, Hiromi Tomioka2, Toshihiko Kaneda2, Yoko Kida2, Masahiro Kaneko2, Hiroshi Fujii2, Yoshihiko Nakajima3, Eiji Katsuyama4.   

Abstract

It has been reported that patients who are positive for both myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane (GBM) antibody have a poor prognosis. We present an autopsy case of anti-GBM disease with a high titer of MPO-ANCA. The patient was a 77-year-old woman with a medical history of idiopathic interstitial pneumonia. After being treated for bacterial pneumonia, she was referred to our hospital for evaluation of non-nephrotic range proteinuria, hematuria, and a course of rapidly progressive glomerulonephritis. Results of urinalysis were 2+ for protein and 3+ for blood, with many dysmorphic red blood cells observed in the urinary sediment. A sample of a 24-h urine collection contained 0.3 g protein. The serum creatinine concentration was 5.0 mg/dl on admission. The patient tested positive for MPO-ANCA at a titer of >640 EU and for anti-GBM antibody at a titer of 14 EU. Renal biopsy revealed glomerulonephritis with crescent formation, and immunofluorescence studies showed that the glomeruli had a generalized linear fluorescence and anti-immunoglobulin G (IgG) and C3 along the peripheral glomerular capillaries. She was diagnosed with anti-GBM disease. Treatment was started with intravenous prednisolone and oral cyclophosphamide, followed by plasma exchange. Despite improved renal function, she died of pulmonary hemorrhage. Autopsy revealed deposits of IgG and C3 in the basement membranes of lung alveoli.

Entities:  

Keywords:  Anti-GBM antibody; Idiopathic interstitial pneumonia; MPO-ANCA; Pulmonary-renal syndrome; RPGN

Year:  2013        PMID: 28509301      PMCID: PMC5411548          DOI: 10.1007/s13730-013-0059-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  11 in total

Review 1.  Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.

Authors:  Abraham Rutgers; Marjan Slot; Pieter van Paassen; Peter van Breda Vriesman; Peter Heeringa; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2005-08       Impact factor: 8.860

2.  Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study.

Authors:  Zhao Cui; Juan Zhao; Xiao-Yu Jia; Sai-Nan Zhu; Qi-Zhuang Jin; Xu-Yang Cheng; Ming-Hui Zhao
Journal:  Medicine (Baltimore)       Date:  2011-09       Impact factor: 1.889

3.  Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.

Authors:  Damian N Meli; Stephan Christen; Stephen L Leib
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

4.  Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.

Authors:  Kimimasa Nakabayashi; Yasunori Fujioka; Toshihiko Nagasawa; Tsuneo Kimura; Kaoruko Kojima; Yoshihiro Arimura; Yasuhiro Arimura; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2011-01-20       Impact factor: 2.801

5.  Comparison of anti-GBM antibodies in sera with or without ANCA.

Authors:  T Hellmark; J L Niles; A B Collins; R T McCluskey; C Brunmark
Journal:  J Am Soc Nephrol       Date:  1997-03       Impact factor: 10.121

6.  Clinical features and outcome of patients with both ANCA and anti-GBM antibodies.

Authors:  Jeremy B Levy; Tarig Hammad; Anne Coulthart; Tammy Dougan; Charles D Pusey
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

7.  Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease.

Authors:  X Bosch; E Mirapeix; J Font; X Borrellas; R Rodríguez; A López-Soto; M Ingelmo; L Revert
Journal:  Clin Nephrol       Date:  1991-09       Impact factor: 0.975

8.  [Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody].

Authors:  Y Arimura; S Minoshima; U Tanaka; A Fujii; M Kobayashi; K Nakabayashi; K Kitamoto; T Nagasawa
Journal:  Ryumachi       Date:  1995-02

9.  Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.

Authors:  T Hellmark; C Johansson; J Wieslander
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

Review 10.  Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Authors:  Spyros A Papiris; Effrosyni D Manali; Ioannis Kalomenidis; Giorgios E Kapotsis; Anna Karakatsani; Charis Roussos
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.